Ivan Bieche Selected Research

cis-diammine(pyridine)chloroplatinum(II)

9/2011

Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ivan Bieche Research Topics

Disease

68	Neoplasms (Cancer) 01/2022 - 07/2004
33	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2002
11	Carcinogenesis 10/2020 - 04/2003
10	Urinary Bladder Neoplasms (Bladder Cancer) 10/2020 - 04/2003
8	Carcinoma (Carcinomatosis) 01/2020 - 04/2003
7	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2007
5	Adenocarcinoma 11/2021 - 10/2008
5	Squamous Cell Carcinoma of Head and Neck 01/2020 - 07/2008
4	Triple Negative Breast Neoplasms 01/2021 - 01/2014
4	Non-Muscle Invasive Bladder Neoplasms 10/2019 - 06/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022 - 10/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 12/2017
3	Inflammation (Inflammations) 01/2018 - 02/2008
3	Melanoma (Melanoma, Malignant) 01/2017 - 09/2007
3	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 06/2015 - 01/2010
2	Liver Diseases (Liver Disease) 01/2021 - 07/2019
2	Alcoholic Fatty Liver 01/2021 - 05/2011
2	Retinal Degeneration 10/2020 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 07/2019 - 03/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2016 - 03/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 06/2015 - 07/2008
2	Glioblastoma (Glioblastoma Multiforme) 03/2014 - 02/2013
2	Inflammatory Breast Neoplasms 10/2013 - 02/2008
2	Meningioma (Meningiomas) 07/2010 - 07/2009
2	Colonic Neoplasms (Colon Cancer) 05/2010 - 05/2009
2	Ischemia 04/2008 - 12/2007
2	Vasculitis (Vasculitides) 04/2007 - 09/2005
2	Polyarteritis Nodosa (Periarteritis Nodosa) 04/2007 - 09/2005
2	Cryoglobulinemia 04/2007 - 09/2005
2	Rheumatic Diseases (Rheumatism) 04/2007 - 09/2005

Drug/Important Bio-Agent (IBA)

20	Messenger RNA (mRNA)IBA 01/2022 - 09/2002
20	Proteins (Proteins, Gene)FDA Link 04/2021 - 09/2002
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2011
10	Estrogen ReceptorsIBA 01/2018 - 07/2004
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2014 - 10/2004
6	Tamoxifen FDA LinkGeneric 02/2012 - 01/2008
6	Estrogen Receptor alphaIBA 02/2009 - 07/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2011
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 07/2009
4	Pharmaceutical PreparationsIBA 06/2021 - 12/2005
4	Formaldehyde (Formol)FDA Link 01/2020 - 01/2017
4	ParaffinIBA 01/2020 - 01/2017
4	Protein Isoforms (Isoforms)IBA 07/2019 - 07/2004
4	Circulating Tumor DNAIBA 03/2019 - 04/2015
4	EnzymesIBA 01/2019 - 04/2003
4	MicroRNAs (MicroRNA)IBA 07/2015 - 06/2013
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 07/2019
3	RNA (Ribonucleic Acid)IBA 09/2020 - 07/2016
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2018
3	ChemokinesIBA 01/2020 - 09/2005
3	CytokinesIBA 01/2020 - 09/2005
3	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2014
3	LigandsIBA 01/2018 - 07/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 01/2008
3	Cerebroside-Sulfatase (Arylsulfatase A)IBA 06/2015 - 01/2010
3	Biological ProductsIBA 01/2015 - 07/2004
3	Estrogens (Estrogen)FDA Link 03/2008 - 07/2004
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022 - 01/2018
2	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
2	NivolumabIBA 01/2022 - 11/2019
2	durvalumabIBA 01/2022 - 01/2021
2	pembrolizumabIBA 11/2021 - 11/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2015
2	B7-H1 AntigenIBA 01/2021 - 01/2017
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 12/2013
2	InterferonsIBA 10/2020 - 10/2010
2	TubulinIBA 10/2020 - 01/2017
2	Cetuximab (Erbitux)FDA Link 01/2020 - 06/2015
2	PlatinumIBA 11/2019 - 09/2011
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 08/2019 - 01/2016
2	Trastuzumab (Herceptin)FDA Link 11/2018 - 11/2005
2	human ERBB2 proteinIBA 01/2018 - 01/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 10/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 04/2007
2	Bevacizumab (Avastin)FDA Link 09/2016 - 03/2014
2	Carboplatin (JM8)FDA LinkGeneric 09/2016 - 07/2008
2	Sunitinib (Sutent)FDA Link 06/2016 - 05/2011
2	Sorafenib (BAY 43-9006)FDA Link 06/2016 - 05/2011
2	Cisplatin (Platino)FDA LinkGeneric 06/2015 - 09/2011
2	Antineoplastic Agents (Antineoplastics)IBA 09/2014 - 09/2011
2	Transcription Factors (Transcription Factor)IBA 02/2013 - 07/2010
2	Sulfoglycosphingolipids (Sulfatides)IBA 08/2012 - 01/2010
2	Fluorouracil (Carac)FDA LinkGeneric 09/2011 - 03/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2011 - 07/2008
2	VimentinIBA 05/2011 - 05/2010
2	Cadherins (E-Cadherin)IBA 05/2011 - 05/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 04/2011 - 03/2010
2	Protein Kinase CIBA 05/2010 - 05/2009
2	Fulvestrant (Faslodex)FDA Link 01/2010 - 10/2008
2	hydroxide ionIBA 01/2010 - 10/2008

Therapy/Procedure

26	Therapeutics 01/2022 - 12/2005
9	Drug Therapy (Chemotherapy) 01/2021 - 03/2008
5	Immunotherapy 01/2022 - 01/2017
4	Precision Medicine 01/2022 - 04/2011
3	Radiotherapy 01/2021 - 09/2016
2	Cystectomy 10/2019 - 01/2017
2	Chemoradiotherapy 11/2018 - 06/2015